4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide

C48H60ClN9O6S — CID 171094266

IUPAC4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide
SMILESCc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C2CN(C3CCN(c4ccc(C(=O)NC5CCC(=O)NC5=O)cc4)CC3)C2)CC1
InChIInChI=1S/C48H60ClN9O6S/c1-29(2)64-42-25-37(31(5)24-41(42)53-48-50-26-38(49)45(55-48)51-39-8-6-7-9-43(39)65(62,63)30(3)4)32-16-20-57(21-17-32)36-27-58(28-36)35-18-22-56(23-19-35)34-12-10-33(11-13-34)46(60)52-40-14-15-44(59)54-47(40)61/h6-13,24-26,29-30,32,35-36,40H,14-23,27-28H2,1-5H3,(H,52,60)(H,54,59,61)(H2,50,51,53,55)
InChIKeyUQOKITVOVSRTMK-UHFFFAOYSA-N
MW926.58 g/mol
LogP6.96
Rot. Bonds14

About 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide

4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide (PubChem CID 171094266) has the molecular formula C48H60ClN9O6S and a molecular weight of 926.58 g/mol. Its IUPAC name is 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide.

Molecular Properties

Compound Name4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide
PubChem CID171094266
Molecular FormulaC48H60ClN9O6S
Molecular Weight926.58 g/mol
Exact Mass925.41
IUPAC Name4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide
SMILESCc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C2CN(C3CCN(c4ccc(C(=O)NC5CCC(=O)NC5=O)cc4)CC3)C2)CC1
InChIInChI=1S/C48H60ClN9O6S/c1-29(2)64-42-25-37(31(5)24-41(42)53-48-50-26-38(49)45(55-48)51-39-8-6-7-9-43(39)65(62,63)30(3)4)32-16-20-57(21-17-32)36-27-58(28-36)35-18-22-56(23-19-35)34-12-10-33(11-13-34)46(60)52-40-14-15-44(59)54-47(40)61/h6-13,24-26,29-30,32,35-36,40H,14-23,27-28H2,1-5H3,(H,52,60)(H,54,59,61)(H2,50,51,53,55)
InChIKeyUQOKITVOVSRTMK-UHFFFAOYSA-N
XLogP6.96
TPSA178.20 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds14
Heavy Atoms65
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500926.58
LogP ≤ 56.96
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide?
The IUPAC name of 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide (CID 171094266) is 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide.
What is the SMILES notation for 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide?
The canonical SMILES for 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide is Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C2CN(C3CCN(c4ccc(C(=O)NC5CCC(=O)NC5=O)cc4)CC3)C2)CC1.
What is the InChIKey of 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide?
The InChIKey is UQOKITVOVSRTMK-UHFFFAOYSA-N. The full InChI is InChI=1S/C48H60ClN9O6S/c1-29(2)64-42-25-37(31(5)24-41(42)53-48-50-26-38(49)45(55-48)51-39-8-6-7-9-43(39)65(62,63)30(3)4)32-16-20-57(21-17-32)36-27-58(28-36)35-18-22-56(23-19-35)34-12-10-33(11-13-34)46(60)52-40-14-15-44(59)54-47(40)61/h6-13,24-26,29-30,32,35-36,40H,14-23,27-28H2,1-5H3,(H,52,60)(H,54,59,61)(H2,50,51,53,55).
What are the key properties of 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide?
4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide has a molecular weight of 926.58 g/mol, XLogP of 6.96, 14 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[3-[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-methyl-5-propan-2-yloxyphenyl]piperidin-1-yl]azetidin-1-yl]piperidin-1-yl]-N-(2,6-dioxopiperidin-3-yl)benzamide is sourced from PubChem (CID 171094266), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).